Genpact Limited Common Stock (G)
Stock · NYSE · Consumer Discretionary
$37.25as of 10/16/2026
Price chart
Active signals
G Signal Track Record
How signals performed across all stocks →What G's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 33 | +0.7% | 58% | September 18, 2026 |
| Bollinger Band Breakdown | 28 | +2.5% | 61% | June 17, 2026 |
| 200-Day Moving Average TouchActive now | 22 | -1.1% | 45% | August 24, 2026 |
| Bollinger Band BreakoutActive now | 19 | +1.6% | 58% | July 16, 2026 |
| Any 20-session window (baseline) | -0.7% | 46% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About G
Genpact Limited, an agentic and advanced technology solutions company, provides digital transformation, business process management, technology, data, analytics, and artificial intelligence (AI) services to enterprises in India, the rest of Asia, North and Latin America, and Europe. Its Financial Services segment offers customer onboarding, customer service, collections, retail and commercial loan operations, payment…
- Sector
- Consumer Discretionary
- Industry
- Professional Services
- Employees
- 141,000
- Website
- www.genpact.com/
Fundamentals
- 1-day range
- $35.82$37.69
- Market cap
- $6.13B
- P/E (trailing)
- 10.52
- P/E (forward)
- 8.33
- EPS (trailing)
- $3.36
- Dividend yield
- 1.64%
- Beta
- 0.59
- Avg. volume
- 2.15M
- Ex-dividend date
- September 10, 2026
- Dividend pay date
- September 24, 2026
How Genpact Limited Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub
Forecasts
11 analyst ratings
Genpact Limited Common Stock Competitors
Chosen by industry and closest market cap.
- GGenpact Limited Common Stock$37.26▼ 0.88%Market cap $6.13BP/E 10.52$26.85$48.64
- FCNFTI Consulting Inc. Common Stock$148.53▲ 1.57%Market cap $4.17BP/E 16.06$129.12$189.3
- RHIRobert Half Inc. Common Stock$33.31▼ 3.14%Market cap $4.16BP/E 30.36$21.83$46.7
- BAHBooz Allen Hamilton Holding Corporation Common Stock$74.26▼ 0.32%Market cap $8.89BP/E 11.52$59.5$109.1
- EXPOExponent Inc. Common Stock$71.85▼ 0.59%Market cap $3.21BP/E 30.85$51.91$81.95
- MANManpowerGroup Common Stock$41.49▼ 5.14%Market cap $2.57BP/E 19.65$25.15$63.88
- HURNHuron Consulting Group Inc. Common Stock$174.86▼ 0.35%Market cap $2.39BP/E 24.12$84.88$186.78
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| G Genpact Limited Common Stock | $6.13B | 10.52 | $37.26 | ▼ 0.88% | $26.85$48.64 |
| FCN FTI Consulting Inc. Common Stock | $4.17B | 16.06 | $148.53 | ▲ 1.57% | $129.12$189.3 |
| RHI Robert Half Inc. Common Stock | $4.16B | 30.36 | $33.31 | ▼ 3.14% | $21.83$46.7 |
| BAH Booz Allen Hamilton Holding Corporation Common Stock | $8.89B | 11.52 | $74.26 | ▼ 0.32% | $59.5$109.1 |
| EXPO Exponent Inc. Common Stock | $3.21B | 30.85 | $71.85 | ▼ 0.59% | $51.91$81.95 |
| MAN ManpowerGroup Common Stock | $2.57B | 19.65 | $41.49 | ▼ 5.14% | $25.15$63.88 |
| HURN Huron Consulting Group Inc. Common Stock | $2.39B | 24.12 | $174.86 | ▼ 0.35% | $84.88$186.78 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Genpact Q2 2026 Earnings Call Transcriptbenzinga · 10/13/2026
- TD SYNNEX Surges 78% YTD: Is the SNX Stock Still Worth Buying?Yahoo · 10/9/2026
- Genpact to Report Third Quarter 2026 ResultsYahoo · 10/8/2026
- Reasons Why Investors Can Consider Buying Genpact Stock NowYahoo · 10/8/2026
- Genpact (NYSE:G) Stands Out as a Quality Stock for Long-Term InvestorsChartMill · 10/7/2026
- QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor RelationsYahoo · 10/7/2026
- 2 Services Stocks Worth Your Attention and 1 That UnderwhelmYahoo · 10/2/2026
- Andersen Group shares are trading higher after UBS maintained its Buy rating on the stock and raised its price target from $32 to $34.Benzinga · 10/1/2026
- INOD vs. EXLS: Which AI & Data Services Stock Has More Upside?Yahoo · 9/29/2026
Insider Activity
Insider Actions →- Balkrishan Kalra · September 14, 2026 · Sale10.0K @ $36.79
- Pandit Sumita · September 9, 2026 · Grant76.7K
- Anil Nanduru · August 19, 2026 · Sale6.2K @ $37.03
- Sameer Dewan · August 14, 2026 · Sale13.3K @ $34.1
- Sameer Dewan · August 14, 2026 · Sale1.7K @ $34.1
- Michael Hal Weiner · August 13, 2026 · Sale5.9K @ $34.04
- Anil Nanduru · August 12, 2026 · Sale11.9K @ $33.92
- Anil Nanduru · August 11, 2026 · Sale17.2K @ $33.96
- Thimaya K. Subaiya · April 23, 2026 · Grant6.5K
- Brian Mark Stevens · April 23, 2026 · Grant6.5K
- Carol Lindstrom · April 23, 2026 · Grant6.5K
- Mark A. Verdi · April 23, 2026 · Grant6.5K
- John M. Hinshaw · April 23, 2026 · Grant6.5K
- Laura Conigliaro · April 23, 2026 · Grant6.5K
- Nicholas C. Gangestad · April 23, 2026 · Grant6.5K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Genpact Highlighted in Recent Stock Analysis Articles
Recent articles from Yahoo and ChartMill have discussed Genpact as a potential option for long-term investors. These pieces focus on the company's quality and position within the services sector. The stock currently trades near a key support level, with analysts maintaining a wide range of price targets.
Genpact Highlighted in Recent Stock Analysis Articles. Recent articles from Yahoo and ChartMill have discussed Genpact as a potential option for long-term investors. These pieces focus on the company's quality and position within the services sector. The stock currently trades near a key support level, with analysts maintaining a wide range of price targets.